Besides their prognostic significance and biologic implications [8], IDH mutations hold considerable importance based on the resultant enzymatic production of oncometabolite D-2-hydroxyglutarate (2HG) [9], which induces broad metabolic reprogramming [10] and functions as a marker of tumor that can confirm mutational status. This evidence concerns the gene IDH2 and neoplasm.